Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-DOTATATE Imaging in Neuroendocrine Tumors

NCT02174679 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02174679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02174679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-DOTATATE Imaging in Neuroendocrine Tumors
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancers expressing somatostatin receptors, carcinoid cancer, medullary thyroid cancer, neuroendocrine tumors